Teva Pharmaceutical Industries Ltd (TEVA) — Capital Reinvestment Ratio
Teva Pharmaceutical Industries Ltd (TEVA) has a Capital Reinvestment Ratio of 0.14x as of June 2026, meaning it reinvests 0% of its operating cash flow (ILA721.91 Million) in capital expenditures (ILA101.58 Million). Check how tangible is Teva Pharmaceutical Industries Ltd's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Teva Pharmaceutical Industries Ltd Capital Reinvestment Ratio (1991–2025)
This chart tracks Teva Pharmaceutical Industries Ltd's Capital Reinvestment Ratio across 34 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Teva Pharmaceutical Industries Ltd.
Annual Capital Reinvestment Ratio for Teva Pharmaceutical Industries Ltd (1991–2025)
Year-by-year Capital Reinvestment Ratio for Teva Pharmaceutical Industries Ltd from 1991 to 2025. See Teva Pharmaceutical Industries Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (ILA) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | ILA3.10 Billion | ILA542.32 Million | ▼ -56.2% |
| 2024 | 0.40x | ILA1.25 Billion | ILA498.00 Million | ▲ +3.9% |
| 2023 | 0.38x | ILA1.37 Billion | ILA526.00 Million | ▲ +11.6% |
| 2022 | 0.34x | ILA1.59 Billion | ILA548.00 Million | ▼ -51.1% |
| 2021 | 0.70x | ILA798.00 Million | ILA562.00 Million | ▲ +48.2% |
| 2020 | 0.48x | ILA1.22 Billion | ILA578.00 Million | ▲ +114.9% |
| 2019 | 0.22x | ILA538.00 Million | ILA119.00 Million | ▼ -16.9% |
| 2018 | 0.27x | ILA2.45 Billion | ILA651.00 Million | ▲ +6.8% |
| 2017 | 0.25x | ILA3.51 Billion | ILA874.00 Million | ▲ +44.5% |
| 2016 | 0.17x | ILA5.22 Billion | ILA901.00 Million | ▲ +23.8% |
| 2015 | 0.14x | ILA5.54 Billion | ILA772.00 Million | ▼ -23.1% |
| 2014 | 0.18x | ILA5.13 Billion | ILA929.00 Million | ▼ -43.1% |
| 2013 | 0.32x | ILA3.24 Billion | ILA1.03 Billion | ▲ +31.9% |
| 2012 | 0.24x | ILA4.57 Billion | ILA1.10 Billion | ▼ -5.2% |
| 2011 | 0.25x | ILA4.13 Billion | ILA1.05 Billion | ▲ +48.4% |
| 2010 | 0.17x | ILA4.14 Billion | ILA710.00 Million | ▼ -19.5% |
| 2009 | 0.21x | ILA3.37 Billion | ILA719.00 Million | ▲ +1.1% |
| 2008 | 0.21x | ILA3.23 Billion | ILA681.00 Million | ▼ -29.5% |
| 2007 | 0.30x | ILA1.81 Billion | ILA542.00 Million | ▲ +57.8% |
| 2006 | 0.19x | ILA2.06 Billion | ILA390.00 Million | ▼ -16.3% |
| 2005 | 0.23x | ILA1.37 Billion | ILA310.10 Million | ▼ -9.1% |
| 2004 | 0.25x | ILA1.25 Billion | ILA311.00 Million | ▼ -24.8% |
| 2003 | 0.33x | ILA626.60 Million | ILA207.50 Million | ▼ -27.0% |
| 2002 | 0.45x | ILA353.70 Million | ILA160.40 Million | ▼ -7.6% |
| 2001 | 0.49x | ILA273.15 Million | ILA134.07 Million | ▼ -9.1% |
| 2000 | 0.54x | ILA165.63 Million | ILA89.42 Million | ▲ +23.6% |
| 1999 | 0.44x | ILA153.61 Million | ILA67.07 Million | ▼ -77.4% |
| 1998 | 1.93x | ILA70.20 Million | ILA135.60 Million | ▲ +489.8% |
| 1997 | 0.33x | ILA193.60 Million | ILA63.40 Million | ▼ -69.3% |
| 1995 | 1.07x | ILA105.40 Million | ILA112.60 Million | ▼ -48.7% |
| 1994 | 2.08x | ILA38.20 Million | ILA79.50 Million | ▲ +73.2% |
| 1993 | 1.20x | ILA37.70 Million | ILA45.30 Million | ▲ +24.1% |
| 1992 | 0.97x | ILA28.20 Million | ILA27.30 Million | ▼ -60.5% |
| 1991 | 2.45x | ILA9.10 Million | ILA22.30 Million | — |